The Annals of Internal Medicine

Anti-Ri Paraneoplastic Neurological Syndrome in Breast Cancer: An a Typical Case and Contemporary Review

Correspondence to Author: Fernando Gonzalez Trujillo 1*, Tomas de los Milagros Rengifo Sandoval 2, Karol Yulissa Cano García 3

1 MD Clinical Neurology, Neuro-Oncology, MSc in Neuroscience, Clínica de Occidente, S.A., Centro Integral de Cáncer, Santiago de Cali, Colombia; Email: fernando.gonzaleztrujillo@gmail.com
2 MD Coloproctology Assistant. Clínica de Occidente, S.A., Santiago de Cali, Colombia; Email: tomasrengifo93@gmail.com
3 MD Emergency Medicine, MD Neurology-Neurosurgery Assistant, Clinica de Occidente, S.A., Santiago de Cali, Colombia; Email: karolcanog.24@gmail.com

DOI: 10.52338/taoim.2025.5230

Abstract:

Background: Paraneoplastic neurological syndromes (PNS) associated with anti-Ri antibodies are characterized by a low prevalence and are frequently overlooked. They are typically associated with breast tumors and exhibit significant variability in clinical presentation.
Objective: To describe an atypical case of anti-Ri PNS in a patient with breast cancer and to review the current literature on its clinical spectrum, diagnostic challenges, and therapeutic approaches.
Methods: We present a case study of a patient with breast carcinoma associated with anti-Ri antibodies. A narrative review of the literature was conducted using PubMed and Scopus (2000-2024) with the terms “anti-Ri,” “paraneoplastic neurological syndrome,” and “breast cancer”.
Statistical Analysis: Measures of central tendency and deviation were employed to describe the data as tables (Mean, SD, median, range, %difference, etc.) and graphs (boxplots, etc.)
Results:Symptoms partially improved with immunotherapy but persisted despite oncologic treatment. Fewer cases of anti-Ri PNS were identified in the literature, with extrapyramidal involvement reported in only a minority, and with limited response to immunomodulatory therapy
Limitations: This is a single case report with a narrative review; potential selection bias in the literature cannot be excluded.
Conclusion: Anti-Ri PNs may present with atypical extrapyramidal features in patients with breast cancer. Early recognition is critical, as timely diagnosis may guide oncologic and immunologic management, although prognosis remains guarded.

Keywords: Paraneoplastic neurological syndrome; anti-Ri antibodies; central nervous system; cerebellar ataxia; autoimmune response.

Citation:

Dr. Fernando Gonzalez Trujillo, Anti-Ri Paraneoplastic Neurological Syndrome in Breast Cancer: An a Typical Case and Contemporary Review. The Annals of Internal Medicine 2025.

Comments

Popular posts from this blog

The European Journal of Cancer

The Journal of Clinical Oncology

World Journal of Clinical Surgery